Immunophenotypic analysis of ovarian endometrioid adenocarcinoma: Correlation with KRAS mutation and the presence of endometriosis

Colin J R Stewart, Michael D Walsh, Charley A Budgeon, Charley Budgeon, Maxine L Crook, Daniel B Buchanan, Daniel D. Buchanan
Pathology · 2013 · vol. 45(6) , pp. 559–566 · doi:10.1097/pat.0b013e3283650ad7 · PMID:24018808 · W2091017768
article OA: closed CC0 ⤵ 7 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed
⚙ AI-generated summary by claude@2026-06, 2026-06-07 ⓘ

This study investigated the immunophenotypic characteristics of ovarian endometrioid adenocarcinoma and their association with KRAS mutations and the presence of endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

mesh:D004715endometriosis

MeSH descriptors

Carcinoma, Endometrioid Carcinoma, Endometrioid Endometriosis Mutation Ovarian Neoplasms Ovarian Neoplasms Proto-Oncogene Proteins ras Proteins Adult Aged Aged, 80 and over Biomarkers, Tumor Biomarkers, Tumor Carcinoma, Endometrioid Carcinoma, Endometrioid Endometriosis Endometriosis Endometriosis Female Humans

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (65)

Cited by (7)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:18:53.335890+00:00
License: CC0 · commercial use OK